MBS item

16055
=====

Administration of Lutetium 177 PSMA with whole body imaging within 36 hours for metastatic castrate-resistant prostate cancer, once per cycle, maximum 4 cycles, following prior imaging assessment and without intervening disease progression.

Category 3 · Therapeutic procedures[Group T3 · subgroup 2](/groups/T3)

Schedule fee$8,208.00

100% benefitGP, out of hospital—

85% benefitOut of hospital$8,103.50

75% benefitIn hospital$6,156.00

The schedule fee for MBS item 16055 is $8,208.00. Medicare pays $8,103.50 (85%) out of hospital, or $6,156.00 (75%) for a privately admitted patient in hospital. Fee effective 1 July 2026.

Gap for what you charge
-----------------------

Your fee$

Out of hospitalIn hospital (private)

Medicare pays$8,103.50

Patient gap$104.50

Bulk billing means accepting $8,103.50 as full payment, with no gap and no extra charges. [Add incentives](/bulk-billing?item=16055)

Item descriptor
---------------

Administration of Lutetium 177 PSMA, followed within 36 hours by whole body Lu-PSMA SPECT, for treatment of a patient with metastatic castrate resistant prostate cancer, if: (a) a service to which item 16050 applies has been provided; and(b) the patient has not developed disease progression while receiving Lutetium 177 PSMA for this condition. Applicable once per cycle, up to a maximum of 4 cycles in the continuing treatment phase.

[Explanatory notes and rules on MBS Online ↗](https://www9.health.gov.au/mbs/fullDisplay.cfm?type=item&q=16055)

Health fund and DVA rates
-------------------------

Total fee each scheme recognises for this item in hospital.

StateNSWVICQLDSAWATASACTNT

Guides
------

- [How Medicare benefits work: schedule fees, 75%, 85% and 100%](/guides/how-medicare-benefits-work)
- [Medicare safety nets explained: original and extended (EMSN) thresholds for 2026](/guides/medicare-safety-nets)
- [In-hospital billing: the 75% benefit, the 25% fund benefit, and no-gap and known-gap schemes](/guides/in-hospital-billing-and-gap-cover)
- [Bulk billing incentives and BBPIP explained: 2026 amounts by MM area](/guides/bulk-billing-incentives)
- [The MBS multiple operation rule and surgical assistant fees](/guides/multiple-operation-rule)
- [Assignment of benefit for bulk billing: the changes from 1 July 2026](/guides/assignment-of-benefit-2026)
- [MBS telehealth rules: the eligible telehealth practitioner and phone items](/guides/mbs-telehealth-rules)
- [GP chronic condition management plans: items 965 and 967 explained](/guides/chronic-condition-management-plans)
- [Medicare billing compliance: claim time limits, records and the 80/20 rule](/guides/medicare-billing-compliance)

Data source: [Australian Government Medicare Benefits Schedule](https://www.mbsonline.gov.au/) · Record updated 1 September 2026. Health fund rates come from each fund's published schedule. Verify item descriptors, rules and fees on [MBS Online](https://www9.health.gov.au/mbs/fullDisplay.cfm?type=item&q=16055) before billing. This is a reference tool, not billing or financial advice.